Results 141 to 150 of about 140,483 (294)
Eosinophilic Gastrointestinal Disease After Pediatric Organ and Bone Marrow Transplantation. [PDF]
Sinai E +5 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
<i>Helicobacter pylori</i> and Cancer: What's the Link? [PDF]
Merola E, Pes GM, Graham DY, Dore MP.
europepmc +1 more source
Volatile organic compounds discriminate between eosinophilic and neutrophilic inflammationin vitro [PDF]
Florence Schleich +5 more
openalex +1 more source
Recent developments in eosinophilic renal neoplasms: what's new, true and important? [PDF]
Trpkov K, Siadat F, Saleeb R.
europepmc +1 more source
SP117CARDIOVASCULAR DISEASE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS [PDF]
Allyson Egan, Milena Bond, David Jayne
openalex +1 more source
Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou +6 more
wiley +1 more source
Mixed cholangiopathy with eosinophilic and autoimmune features: a case report. [PDF]
Shen H +4 more
europepmc +1 more source

